High levels of Cdc42-interacting protein 4 (CIP4) in invasive breast cancer cells (Pichot et al, 2010), such as in BLBCs, might offer an alternative means by which Cdc42 inhibits c-Cbl function. This evidence concerns the gene TRIP10 and breast carcinoma.